Literature DB >> 19458369

Optimal management of acute coronary syndromes.

L David Hillis, Richard A Lange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19458369     DOI： 10.1056/NEJMe0902632

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.

Authors:  David M Kent; Peter M Rothwell; John P A Ioannidis; Doug G Altman; Rodney A Hayward
Journal:  Trials       Date:  2010-08-12       Impact factor: 2.279

2.  Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.

Authors:  Kade Birkeland; David Parra; Robert Rosenstein
Journal:  J Blood Med       Date:  2010-09-01

3.  Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.

Authors:  Tamara Jakimov; Igor Mrdović; Branka Filipović; Marija Zdravković; Aleksandra Djoković; Saša Hinić; Nataša Milić; Branislav Filipović
Journal:  Croat Med J       Date:  2017-12-31       Impact factor: 1.351

Review 4.  Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Authors:  Shailja V Parikh; Ellen C Keeley
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.